2026/2670(DEA)
Infection with bluetongue virus (serotype 1-24) disease control measures
Basic information
2026/2670(DEA)
DEA - Delegated acts procedure
Supplementing 2013/0136(COD)
Subject
4.20.01 Medicine, diseases
Status
Procedure completed - delegated act enters into force
Key players
-
European Parliament
Committee responsible Rapporteur Appointed Committee for opinion Rapporteur for opinion Appointed
Key events
| Date | Event | Reference | Summary |
|---|---|---|---|
| 27/03/2026 | Non-legislative basic document published | C(2026)00902 | |
| 27/03/2026 | Initial period for examining delegated act 2 month(s) | ||
| 29/04/2026 | Committee referral announced in Parliament | ||
| 04/06/2026 | Delegated act not objected by Parliament |
Technical information
| Procedure reference | 2026/2670(DEA) |
|---|---|
| Procedure type | DEA - Delegated acts procedure |
| Procedure subtype | Examination of delegated act |
| Amendments and repeals | Supplementing 2013/0136(COD) |
| Stage reached in procedure | Procedure completed - delegated act enters into force |
| Committee dossier |
AGRI/10/05531
|
Documentation gateway
-
Document type Reference Date Summary Non-legislative basic document C(2026)00902 27/03/2026
Additional information
| Source | Document | Date |
|---|---|---|
| European Commission | EUR-Lex |